Compugen Ltd

The Therapeutic Modulation of Cytokines with Pierre Ferré, VP of Pre-Clinical Development, Compugen hubs.la/Q028P1rH0

We're thrilled to welcome Dr. Granit from @CompugenLtd to #NucleaiAcademy lecture series. Dive deep into the transformative world of #SpatialTranscriptomics & it's pivotal role in tumor biology research hubs.li/Q023rxpy0 #Immunotherapy #PrecisionOncology #SpatialBiology

Listening to "Applying multiomics to novel target discovery in immuno-oncology" at podcast.insights.bio/1986893/133684…

Join us on May 23rd at 12pm ET for a KOL webinar with @CompugenLtd, featuring Drew Pardoll, MD, PhD (@dpardol1) discussing Compugen's differentiated DNAM-1 axis hypothesis, suggesting the simultaneous blockade of PVRIG, TIGIT and PD-1. Register here: lifesci.events/Compugen $CGEN

Join us on May 23rd at 12pm ET for a KOL webinar with @CompugenLtd, featuring Drew Pardoll, MD, PhD (@dpardol1) discussing Compugen's differentiated DNAM-1 axis hypothesis, suggesting the simultaneous blockade of PVRIG, TIGIT and PD-1. Register here: lifesci.events/Compugen $CGEN

$CGEN Compugen says it is pioneering a 'computational discovery approach' to cancer immunotherapy tinyurl.com/2ooo772q @CompugenLtd #CGEN

Our CEO Anat Cohen-Dayag speaks to @KarenJagoda about the computational approach powering our discovery and clinical development and its promise for cancer patients who've exhausted all other treatment options. Listen: empoweredpatientradio.com/computational-… #Immunooncology #TIGIT #PVRIG #DNAM1

I’m excited to share that our recent research findings on the accurate #singlecellanalysis of #PVRIG and its corrected #genemodel are now available on @biorxiv_bioinfo 🧬📢biorxiv.org/content/10.110…

Proud of our CEO Dr. Anat Cohen-Dayag. Anat recently sat down w/ @Gold_pharma to discuss her career journey and @CompugenLtd's transformation to a clinical-stage cancer #immunotherapy company and pioneer in computational target discovery. Check out the article! #LeadershipMatters

Honored to be named Best Clinical-Stage Immuno-oncology Development Company by @Global_H_Pharma. This award recognizes the promise of our work on the DNAM-1 axis hypothesis, which positions us to lead in this new area of cancer immunotherapy. ghp-news.com/awards/interna… #DNAM1 #TIGIT

CEO @AnatDayag spoke with @NoCamels about the inequalities #womenintech face, including fewer leadership roles. We’re grateful for her dedication and are excited for our future with her at the helm. Read more: nocamels.com/2022/07/women-… #womeninscience

Compugen Still Confident Of Its TIGIT Strategy Despite Roche’s Setbacks scrip.pharmaintelligence.informa.com/articles/2022/…

Compugen’s VP for Preclinical Development, will be presenting on PVRIG and TIGIT immune checkpoint blockade in cancer: Emerging translational data from clinical trials at the upcoming @congress_AIS #immunotherapy #immunooncology #ais2022

Compugen’s Henry Adewoye and Ari Krashin are delighted to be participating at this year’s JMP Securities LLC Life Sciences Conference in New York City. You can listen in live to the fireside chat moderated by Reni Benjamin by going to ir.cgen.com/news-and-event… #checkpoint

Compugen's @AnatDayag and Ari Krashin are delighted to be participating at this year’s #JefferiesHealthcare Conference in New York City. You can listen in live to the fireside chat moderated by Chris Howerton, Ph.D. on lnkd.in/eieVrYYz #jefferies #immunotherapy

Compugen’s SVP, Research and Drug Discovery, Eran Ophir, will present at the upcoming Biomed Israel Conference in Tel Aviv on May 12th. Learn more about the event on kenes-exhibitions.com/biomed/program…

Today, Compugen's Roy Granit is presenting at the Keystone Symposium: Cancer Immunotherapy: Decoding the Cancer Immunity Interactome. You can find details on Roy’s presentation on ir.cgen.com/news-and-event…

Today we will be presenting at the @oppenheimer 32nd Annual Healthcare Conference #OpcoHC22. For more details on the presentation click here: ir.cgen.com/news-and-event… and be sure to check out the #webcast here: wsw.com/webcast/oppenh…

On #InternationalWomensDay we are proud to have women representing 53% of our workforce and to be led by an inspiring female President and CEO, Anat Cohen-Dayag @AnatDayag #BreakTheBias #IWD2022